LinkedIn Profile

Access Kineta historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:kineta 2178617 May 29th, 2019 12:00AM Kineta, Inc. 1.1K 32.00 Open Biotechnology May 29th, 2019 08:53AM May 29th, 2019 08:53AM Kineta is a clinical stage biotechnology company committed to developing disruptive life science technologies in immuno-oncology, neuroscience and biodefense Open Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, Neuroscience Open Seattle WA US Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 17th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 16th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 15th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 14th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 13th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 12th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 11th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 10th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology
private:kineta 2178617 Feb 9th, 2018 12:00AM Kineta, Inc. 854 38.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Kineta is a privately held emerging biotech company that was founded in 2008. Our mission is to develop novel immunotherapies that transform patients’ lives. Kineta has established a focused pipeline of life improving therapies that address critical unmet patient needs. We have leveraged our expertise in immunology to advance novel drug development programs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta fills a void in the biopharmaceutical industry by efficiently advancing first in class immunotherapies from discovery to clinical proof of concept. Kineta Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.